Strategy

Sep 19, 2018
Pharmaceutical Executive
Executives highlight approaches around recent landmark approvals for digital medicine and gene therapy.
Sep 10, 2018
Paras Kumar examines the critical role that patent research has within life sciences beyond its traditional uses by the R&D and legal departments.
Aug 21, 2018
Chad Storlie draws on military training to outline how all industries and organizations can create great junior leaders.
Aug 07, 2018
Pharmaceutical Executive
Commercial leaders can boost product launches with a data-driven roadmap, writes Erik Cruz.
Aug 06, 2018
Daniel Patrick discusses the small biotech company journey from an incubator of ideas to the ability to shepherd an R&D asset through its pipeline to achieving commercial success.
Jul 18, 2018
The Pfizer restructuring will be a case study in whether corporate restructuring & innovation can co-exist or whether M&A is the more viable answer, writes Edward Pratesi.
Jul 18, 2018
Alison Horstmeyer discusses how pharma executives can apply four attributes of curiosity to negotiate VUCA (volatile, uncertain, complex, and ambiguous) conditions and improve organizational outcomes.
Jul 13, 2018
Pharmaceutical Executive
Outlining a real-world case study in which building and operationalizing a patient- and customer-centric commercialization strategy drove a successful launch from a “standing start.”
Jul 08, 2018
Pharmaceutical Executive
Kevin J. Slatkavitz discusses how navigating compliance risks requires so much more than policies and procedures.
Jun 22, 2018
Josh Reisberg outlines the foundation of a broad defense strategy for generic companies embroiled in Hatch-Waxman litigations.
native1_300x100
lorem ipsum